Venous thromboembolism in paediatric practice

Paediatric Anaesthesia

Volumn 9, Issue 6, 1999, Pages 475-484

  Clark, Deborah J ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLOOD CLOTTING; CHILD; ECHOGRAPHY; FIBRINOLYTIC THERAPY; HEMOSTASIS; HUMAN; LUNG EMBOLISM; MEDICAL INFORMATION; MEDICAL PRACTICE; PERIOPERATIVE PERIOD; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

CHILD; HUMANS; INTRAOPERATIVE PERIOD; VENOUS THROMBOSIS;

EID: 0032707664     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.1999.00409.x     Document Type: Review

References (71)

1. Camplin GE, Devlin H, Hoile R et al. The Report of the National Confidential Enquiry into Perioperative Deaths 1991/1992. London: Eyre & Spottiswoode, 1993: 64-199.
2. Andrew M, David M, Adams M et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251-1257.
3. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thrombosis Haemostasis 1995; 74: 415-425.
4. Thromboembolic Risk Factors Consensus Group (THRIFT). Risk and prophylaxis for venous thromboembolism in hospital patients. Br Med J 1994; 308: 235-246.
5. Uden A. Thromboembolic complications following scoliosis surgery in Scandinavia. Acta Orthopaed Scand 1979; 50: 175-178.
6. Bauer K, Rosenberg R. The pathophysiology of prethrombotic states in humans. Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350.
7. Whitlock JA, Janco RL, Phillips JA. Inherited hypercoaguable states in children. Am J Hematol/Oncol 1989; 11: 170-173.
8. Andrew M, Paes B, Milner R et al. Development of the human coagulation system in the full term infant. Blood 1987; 70: 165-172.
9. Andrew M, Paes B, Milner R et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
10. Andrew M, Paes B, Johnston M. Development of the haemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
11. Andrew M, Vegh P, Johnson M et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
12. Andrew M, Mitchell L, Vegh P et al. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994; 72: 836-842.
13. 2 macroglobulin concentration and its variation with age and sex. Clin Chim Acta 1967; 15: 113-120.
14. Manco-Johnson M, Nuss R, Jacobson L et al. Activated protein C cofactor activity is increased in neonates. Blood 1994; 84 (suppl. 10): 85a.
15. Aurousseau M, Amiral J, Boffa M. Level of plasma thrombomodulin in neonates and children. Thromb Haemost 1991; 65: 1232.
16. Sanders J, Holtkamp C Buchanan G. The bleeding time may be longer in children than in adults. Am J Hematol/Oncol 1990; 12: 314-318.
17. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993; 123: 337-346.
18. Williams EC. Catheter related thrombosis. Clin Cardiol 1990; 13: 34-36.
19. Andrew M, Marzinotto V, Pencharz P et al. A cross-sectional study of catheter related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126: 358-363.
20. Derish M, Smith D, Frankel L. Venous catheter thrombosis formation and pulmonary embolism in children. Pediatr Pulmonol 1995; 20: 349-354.
21. Rockoff M, Vacanti J. Fatal pulmonary embolism following removal of a central venous catheter. J Pediatr Surg 1984; 19: 307-309.
22. Goodman NM, Faulkner MJ. Intraoperative pulmonary embolism in a child. Br J Anaesth 1987; 59: 1059-1062.
23. Korones DN, Buzzard CJ, Asselin B et al. Right atrial thrombi in children with cancer and indwelling catheters. J Pediatr 1996; 128: 841-846.
24. Nguyen LT, Laberge JM, Guttman FM et al. Spontaneous deep vein thrombosis in childhood and adolescence. J Pediatr Surg 1986; 21: 640-643.
25. Sifontes MT, Nuss R, Hunger SP et al. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol 1997; 96: 484-489.
26. Mehis O, Anrassy K, Koderisch J et al. Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. J Pediatr 1987; 110: 862-867.
27. Andrew M, Brooker L. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996; 10: 88-99.
28. Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation and thromboembolism in nephrotic syndrome. Nephron 1995; 70: 271-281.
29. Montes de Oca MA, Babron Mc, Bletry O et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991; 66: 713-717.
30. Nuss R, Hays T, Chudgar U et al. Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli. J Pediatr Hematol/Oncol 1997; 19: 202-207.
31. Caporali R, Ravelli A, Ramenghi B et al. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child 1992; 67: 1384-1386.
32. Nowak-Gottl U, Debus O, Findeisen M et al. Lipoprotein (a): its role in childhood thromboembolism. Pediatrics 1997; 99: E11.
33. Lee JCL, Spittell JA, Sauer WG et al. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 1968; 54: 76-85.
34. Calderon A, Wong JW, Becker LE. Multiple cerebral venous thromboses in a child with ulcerative colitis. Clin Pediatr 1993; 32: 169-171.
35. Lees A. Thromboembolic complications in children and adolescents: who is at risk? J Pediatr Health Care 1995; 10: 222-224.
36. Wise RC, Todd JK. Spontaneous, lower-extremity venous thrombosis in children. Am J Dis Children 1973; 126: 766-769.
37. Leslie IJ, Dorgan JC, Bentley G. Deep venous thrombosis in a child during halofemoral traction. Lancet 1979; 20: 847-848.
38. McKenzie PJ. Deep venous thrombosis and anaesthesia. Br J Anaesth 1991; 66: 4-6.
39. Rosen SB, Sturk A. Activated protein C resistance - a major risk factor for thrombosis. Eur J Clin Chem Clin Biochem 1997; 35: 501-516.
40. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism charecterised by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
41. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
42. Schafer AI. The hypercoagulable states. Ann Intern Med 1985; 102: 814-828.
43. Dahlback B, Zoller B, Hillarp A. Inherited resistance to activated protein C caused by presence of the FV. Q506 allele as a basis of venous thrombosis. Haemostasis 1996; 26 (suppl. 4): 301-314.
44. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. The Lancet 1995; 28: 1133-1134.
45. Ridker PM, Miletich JP, Hennekens CH et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. J Am Med Assoc 1997; 277: 1305-1307.
46. Nowak-Gottl U, Koch HG, Aschka I et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996; 92: 992-998.
47. Sifontes MT, Nuss R, Jacobson LJ et al. Thrombosis in otherwise well children with the factor V Leiden mutation. J Pediatr 1996; 128: 324-328.
48. Aschka T, Aumann V, Bergmann F et al. Prevelance of factor V Leiden in children with thromboembolism. Eur J Pediatr 1996; 155: 1009-1014.
49. Glueck CJ, Brandt G, Guippo R et al. Resistance to activated protein C and Legg-Perthes disease. Clin Orthop 1997; 5: 139-152.
50. Seixas CA, Hessel G, Ribeiro CC et al. Factor V Leiden is not common in children with portal vein thrombosis. Thromb Haemost 1997; 77: 258-261.
51. Sharitt I, Brenner B, Lanir N et al. Coexistence of acquired protein S and protein C deficiency and the Arg506 Gln mutation in factor Va in a child with severe thromboembolic disease. Acta Paediatr Scand 1998; 87: 349-350.
52. Sternberg TL, Bailey MK, Lazarchick J et al. Protein C deficiency as a cause of pulmonary embolism in the perioperative period. Anesthesiology 1991; 74: 364-366.
53. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903.
54. Bick RL. Platelet function defects associated with hemorrhage or thrombosis. Med Clinics North Am 1994; 78: 577-607.
55. Buck JR, Connors RH, Coon WW et al. Pulmonary embolism in children. J Pediatr Surg 1981; 16: 385-391.
56. Stevenson GF, Stevenson FL. Pulmonary embolism in childhood. J Pediatr 1949; 00: 62-69.
57. Bernstein D, Coupey S, Schonberg SK. Pulmonary embolism in adolescents. Am J Dis Children 1986; 140: 667-671.
58. Green RM, Meyer TJ, Dunn M et al. Pulmonary embolism in younger adults. Chest 1992; 101: 1507-1511.
59. Butler PJ, Wheeler RA, Spargo PM. Life threatening complications during anaesthesia in a patient with a ventriculoatrial shunt and pulmonary hypertension. Anaesthesia 1990; 45: 946-948.
60. David M, Manco-Johnson M, Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. Thromb Haemost 1995; 74: 791-792.
61. Tait RC, Ladusans EJ, El-Metaal M et al. Oral anticoagulation in paediatric patients: dose requirements and complications. Arch Dis Child 1996; 74: 228-231.
62. Andrew M, Marzinotto V, Brooker LA et al. Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 1994; 71: 265-269.
63. Andrew M, Marzinotto V, Massicotte P et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994; 35: 78-83.
64. Silver D. An overview of venous thromboembolism prophylaxis. Am J Surg 1991; 161: 537-540.
65. Dillon P, Fox P, Berg C et al. Recombinant tissue plasminogen activator for neonatal and paediatric vascular thrombolytic therapy. J Pediatr Surg 1993; 28: 1264-1269.
66. Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 1995; 108 (suppl. 4): 506-521.
67. Antiplatelet Trialists Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994; 308: 235-246.
68. Bulingham A, Strunin L. Prevention of postoperative venous thromboembolism. Br J Anaesth 1995; 75: 622-630.
69. Chong BH. Prevention of postoperative venous thromboembolism. Med J Austral 1996; 164: 646-647.
70. Bergmann J-F, Elkharrat D. Prevention of venous thromboembolic risk in non-surgical patients. Haemostasis 1996; 26 (suppl. 2): 16-23.
71. Ashby EC, Ashford NS, Campbell MJ. Posture, blood velocity in the common femoral vein, and prophylaxis of venous thromboembolism. Lancet 1995; 345: 419-421.